The CONVINCE randomized trial found positive effects on quality of life for patients with chronic kidney disease treated with hemodiafiltration
Matthias Rose(Humboldt-Universität zu Berlin), Peter J. Blankestijn(Utrecht University), Krister Cromm(Humboldt-Universität zu Berlin), Robin W.M. Vernooij(Utrecht University), Mark Woodward(UNSW Sydney), Cláudia Barth(Université de Montpellier), Jörgen Hegbrant(Lund University), Adrian Covic(Grigore T. Popa University of Medicine and Pharmacy), Bernard Canaud(Université de Montpellier), Felix Fischer(Humboldt-Universität zu Berlin), Kathrin I. Fischer(Boehringer Ingelheim (Germany)), Giovanni FM Strippoli(The University of Sydney), Michiel L. Bots(Utrecht University), Andrew Davenport(The Royal Free Hospital), Andrea M. Cucui(Université de Montpellier), Hanna Jaha(Humboldt-Universität zu Berlin), Mariëtta Török(Université de Montpellier), Gregor Liegl(Humboldt-Universität zu Berlin), Carina Hockham(The George Institute for Global Health), Anna Schappert(Humboldt-Universität zu Berlin)
Cited by 48
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008
|Journal of Clinical Epidemiology|2010|5.1k